7.5 Evidence-Based Practice for PTAs
Key Takeaways
- The research evidence hierarchy ranks systematic reviews highest, followed by randomized controlled trials (RCTs), cohort studies, case-control studies, case series, and expert opinion.
- A p-value below 0.05 indicates a result is statistically significant — unlikely to be due to chance alone.
- The minimal clinically important difference (MCID) is the smallest change a patient perceives as meaningful, distinct from mere statistical significance.
- Sensitivity measures how well a test detects disease (rule out when negative); specificity measures how well it identifies healthy patients (rule in when positive).
- A PTA applies evidence by carrying out the PT-selected, evidence-based protocol within the plan of care — not by independently changing the protocol based on a personal literature review.
The Evidence Hierarchy
Evidence-based practice integrates the best available research, clinical expertise, and patient values. Study designs are ranked by how well they control bias.
| Rank | Study Design | Strength |
|---|---|---|
| 1 | Systematic review / meta-analysis | Strongest — synthesizes many studies |
| 2 | Randomized controlled trial (RCT) | Strong — randomization limits bias |
| 3 | Cohort study | Moderate — follows groups over time |
| 4 | Case-control study | Moderate-low — compares those with and without an outcome |
| 5 | Case series / case report | Weak — no comparison group |
| 6 | Expert opinion | Weakest — no systematic data |
When two studies conflict, the design higher on this hierarchy generally carries more weight.
Basic Statistics for the NPTE-PTA
| Term | Meaning |
|---|---|
| p-value | Probability the result occurred by chance; p < 0.05 is considered statistically significant |
| MCID (minimal clinically important difference) | Smallest change a patient perceives as meaningful or worthwhile |
| NNT (number needed to treat) | Number of patients who must be treated for one to benefit; a lower NNT is better |
| Sensitivity | Ability of a test to correctly identify patients who HAVE the condition |
| Specificity | Ability of a test to correctly identify patients who do NOT have the condition |
| PPV (positive predictive value) | Probability a patient with a positive test truly has the condition |
| NPV (negative predictive value) | Probability a patient with a negative test truly does not have the condition |
Statistical vs. clinical significance: a study can show a statistically significant change (p < 0.05) that is still smaller than the MCID — meaning the change is real but too small for the patient to notice. Both matter.
Sensitivity vs. specificity memory hooks: SnNOut — a highly Sensitive test, when Negative, helps rule the condition OUT. SpPIn — a highly Specific test, when Positive, helps rule the condition IN.
How a PTA Applies Evidence
This is the exam's key distinction. A PTA uses evidence within the plan of care (POC), not to override it:
- The PT evaluates the patient and selects an evidence-based intervention and protocol as part of the POC.
- The PTA implements that protocol faithfully, collects objective data on the patient's response, and reports findings back to the PT.
- A PTA who reads a journal article suggesting a different approach should discuss it with the supervising PT — the PTA does not unilaterally substitute a new protocol.
- The PTA contributes to evidence-based care by ensuring the prescribed protocol is delivered with correct dosage, parameters, and progression, and by communicating when a patient is not responding as expected.
Understanding research lets a PTA recognize when reported progress is meaningful (exceeds the MCID) and explain to patients why the prescribed program is appropriate — without stepping outside the PTA scope of practice.
A PTA reads a recent randomized controlled trial (RCT) suggesting a different exercise protocol may work better than the one the supervising PT selected. What is the appropriate action?
A study reports that a treatment produced a change in outcome scores with a p-value of 0.03, but the change was smaller than the validated minimal clinically important difference (MCID). How should this be interpreted?
Match each biostatistics term to its definition.
Match each item on the left with the correct item on the right